Evolent End Period Cash Flow vs Other Non Cash Items Analysis

EVH Stock

USD 11.43 0.36 3.25%

Evolent Health financial indicator trend analysis is much more than just examining Evolent Health latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Evolent Health is a good investment. Please check the relationship between Evolent Health End Period Cash Flow and its Other Non Cash Items accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evolent Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

For more detail on how to invest in Evolent Stock please use our How to Invest in Evolent Health guide.

End Period Cash Flow vs Other Non Cash Items

End Period Cash Flow vs Other Non Cash Items Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Evolent Health End Period Cash Flow account and Other Non Cash Items. At this time, the significance of the direction appears to have very week relationship.

The correlation between Evolent Health's End Period Cash Flow and Other Non Cash Items is 0.2. Overlapping area represents the amount of variation of End Period Cash Flow that can explain the historical movement of Other Non Cash Items in the same time period over historical financial statements of Evolent Health, assuming nothing else is changed. The correlation between historical values of Evolent Health's End Period Cash Flow and Other Non Cash Items is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which End Period Cash Flow of Evolent Health are associated (or correlated) with its Other Non Cash Items. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Non Cash Items has no effect on the direction of End Period Cash Flow i.e., Evolent Health's End Period Cash Flow and Other Non Cash Items go up and down completely randomly.

Correlation Coefficient

0.2

Relationship Direction	Positive
Relationship Strength	Very Weak

View All Relationships

End Period Cash Flow

Other Non Cash Items

Most indicators from Evolent Health's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Evolent Health current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evolent Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

For more detail on how to invest in Evolent Stock please use our How to Invest in Evolent Health guide.As of now, Evolent Health's Issuance Of Capital Stock is increasing as compared to previous years. The Evolent Health's current Sales General And Administrative To Revenue is estimated to increase to 0.55, while Selling General Administrative is projected to decrease to under 236.7 M.

	2021	2022	2023	2024 (projected)
Total Revenue	908.0M	1.4B	2.0B	2.1B
Depreciation And Amortization	60.0M	90.3M	123.4M	129.6M

Total Revenue Depreciation And Amortization

Evolent Health fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Intangible Assets	Other Liab	Current Deferred Revenue	Short Term Investments	Non Current Liabilities Total	Inventory	Property Plant And Equipment Gross
Total Assets		0.87	0.89	0.86	0.68	0.76	-0.64	0.61	0.7	0.99	0.87	0.48	0.65	0.87	0.85	0.54	0.78	0.92	0.85	0.98	0.25	-0.48	0.24	0.9	-0.21	0.73
Other Current Liab	0.87		0.99	0.53	0.63	0.85	-0.89	0.36	0.56	0.86	0.91	0.32	0.52	0.97	0.72	0.29	0.83	0.98	0.75	0.92	0.35	-0.78	0.17	0.95	-0.34	0.8
Total Current Liabilities	0.89	0.99		0.58	0.69	0.83	-0.9	0.41	0.63	0.87	0.91	0.37	0.58	0.95	0.77	0.37	0.84	0.98	0.8	0.92	0.36	-0.74	0.24	0.93	-0.39	0.83
Total Stockholder Equity	0.86	0.53	0.58		0.67	0.44	-0.32	0.74	0.76	0.84	0.6	0.58	0.69	0.52	0.85	0.68	0.61	0.62	0.84	0.74	0.17	-0.05	0.3	0.6	-0.2	0.6
Property Plant And Equipment Net	0.68	0.63	0.69	0.67		0.56	-0.74	0.53	0.71	0.66	0.61	0.69	0.64	0.51	0.84	0.78	0.79	0.65	0.75	0.6	0.47	-0.32	0.17	0.6	-0.74	0.86
Net Debt	0.76	0.85	0.83	0.44	0.56		-0.77	0.21	0.21	0.8	0.85	0.14	0.12	0.89	0.55	0.29	0.75	0.89	0.5	0.85	0.1	-0.69	-0.12	0.92	-0.17	0.71
Retained Earnings	-0.64	-0.89	-0.9	-0.32	-0.74	-0.77		-0.27	-0.49	-0.62	-0.79	-0.33	-0.44	-0.8	-0.66	-0.31	-0.85	-0.85	-0.66	-0.7	-0.42	0.77	-0.13	-0.8	0.59	-0.87
Accounts Payable	0.61	0.36	0.41	0.74	0.53	0.21	-0.27		0.65	0.54	0.39	0.53	0.61	0.32	0.63	0.56	0.54	0.44	0.71	0.49	0.05	-0.01	0.31	0.42	-0.13	0.49
Cash	0.7	0.56	0.63	0.76	0.71	0.21	-0.49	0.65		0.62	0.5	0.78	0.94	0.44	0.81	0.58	0.6	0.56	0.9	0.57	0.61	-0.14	0.4	0.46	-0.54	0.6
Non Current Assets Total	0.99	0.86	0.87	0.84	0.66	0.8	-0.62	0.54	0.62		0.88	0.41	0.57	0.87	0.82	0.53	0.75	0.92	0.79	0.98	0.19	-0.49	0.2	0.91	-0.18	0.71
Non Currrent Assets Other	0.87	0.91	0.91	0.6	0.61	0.85	-0.79	0.39	0.5	0.88		0.19	0.47	0.94	0.78	0.25	0.76	0.93	0.72	0.92	0.15	-0.76	0.17	0.91	-0.31	0.81
Other Assets	0.48	0.32	0.37	0.58	0.69	0.14	-0.33	0.53	0.78	0.41	0.19		0.73	0.18	0.58	0.72	0.49	0.36	0.62	0.35	0.77	0.15	0.01	0.32	-0.46	0.33
Cash And Short Term Investments	0.65	0.52	0.58	0.69	0.64	0.12	-0.44	0.61	0.94	0.57	0.47	0.73		0.41	0.79	0.53	0.53	0.52	0.82	0.53	0.59	-0.14	0.5	0.42	-0.51	0.52
Net Receivables	0.87	0.97	0.95	0.52	0.51	0.89	-0.8	0.32	0.44	0.87	0.94	0.18	0.41		0.67	0.18	0.79	0.98	0.67	0.95	0.2	-0.77	0.12	0.97	-0.15	0.71
Common Stock Shares Outstanding	0.85	0.72	0.77	0.85	0.84	0.55	-0.66	0.63	0.81	0.82	0.78	0.58	0.79	0.67		0.63	0.77	0.77	0.91	0.77	0.35	-0.38	0.29	0.72	-0.48	0.83
Other Current Assets	0.54	0.29	0.37	0.68	0.78	0.29	-0.31	0.56	0.58	0.53	0.25	0.72	0.53	0.18	0.63		0.48	0.37	0.53	0.41	0.25	0.19	0.28	0.33	-0.37	0.47
Other Stockholder Equity	0.78	0.83	0.84	0.61	0.79	0.75	-0.85	0.54	0.6	0.75	0.76	0.49	0.53	0.79	0.77	0.48		0.85	0.76	0.78	0.3	-0.5	0.15	0.84	-0.38	0.82
Total Liab	0.92	0.98	0.98	0.62	0.65	0.89	-0.85	0.44	0.56	0.92	0.93	0.36	0.52	0.98	0.77	0.37	0.85		0.77	0.97	0.3	-0.71	0.14	0.99	-0.26	0.78
Total Current Assets	0.85	0.75	0.8	0.84	0.75	0.5	-0.66	0.71	0.9	0.79	0.72	0.62	0.82	0.67	0.91	0.53	0.76	0.77		0.78	0.45	-0.36	0.32	0.7	-0.45	0.8
Intangible Assets	0.98	0.92	0.92	0.74	0.6	0.85	-0.7	0.49	0.57	0.98	0.92	0.35	0.53	0.95	0.77	0.41	0.78	0.97	0.78		0.2	-0.59	0.18	0.96	-0.14	0.71
Other Liab	0.25	0.35	0.36	0.17	0.47	0.1	-0.42	0.05	0.61	0.19	0.15	0.77	0.59	0.2	0.35	0.25	0.3	0.3	0.45	0.2		-0.16	-0.17	0.24	-0.6	0.24
Current Deferred Revenue	-0.48	-0.78	-0.74	-0.05	-0.32	-0.69	0.77	-0.01	-0.14	-0.49	-0.76	0.15	-0.14	-0.77	-0.38	0.19	-0.5	-0.71	-0.36	-0.59	-0.16		0.07	-0.69	0.34	-0.64
Short Term Investments	0.24	0.17	0.24	0.3	0.17	-0.12	-0.13	0.31	0.4	0.2	0.17	0.01	0.5	0.12	0.29	0.28	0.15	0.14	0.32	0.18	-0.17	0.07		0.02	-0.16	0.25
Non Current Liabilities Total	0.9	0.95	0.93	0.6	0.6	0.92	-0.8	0.42	0.46	0.91	0.91	0.32	0.42	0.97	0.72	0.33	0.84	0.99	0.7	0.96	0.24	-0.69	0.02		-0.15	0.72
Inventory	-0.21	-0.34	-0.39	-0.2	-0.74	-0.17	0.59	-0.13	-0.54	-0.18	-0.31	-0.46	-0.51	-0.15	-0.48	-0.37	-0.38	-0.26	-0.45	-0.14	-0.6	0.34	-0.16	-0.15		-0.66
Property Plant And Equipment Gross	0.73	0.8	0.83	0.6	0.86	0.71	-0.87	0.49	0.6	0.71	0.81	0.33	0.52	0.71	0.83	0.47	0.82	0.78	0.8	0.71	0.24	-0.64	0.25	0.72	-0.66

Click cells to compare fundamentals

Evolent Health Account Relationship Matchups

Evolent Health fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	1.5B	1.4B	1.4B	1.8B	2.7B	2.8B
Other Current Liab	129.2M	319.9M	323.3M	356.3M	600.5M	630.6M
Total Current Liabilities	192.8M	401.8M	445.5M	433.4M	674.2M	708.0M
Total Stockholder Equity	922.4M	619.6M	693.6M	859.4M	1.1B	706.1M
Property Plant And Equipment Net	157.3M	144.0M	131.6M	136.9M	90.2M	84.7M
Net Debt	267.8M	19.3M	14.2M	287.9M	452.0M	474.6M
Retained Earnings	(252.0M)	(589.2M)	(626.8M)	(606.2M)	(719.2M)	(683.2M)
Accounts Payable	37.5M	32.0M	96.1M	57.2M	48.2M	48.9M
Cash	101.0M	340.5M	266.3M	188.2M	192.8M	176.4M
Non Current Assets Total	1.3B	824.1M	895.5M	1.3B	2.0B	2.1B
Non Currrent Assets Other	8.3M	7.3M	13.0M	32.3M	33.0M	34.7M
Other Assets	92.0M	186.5M	52.4M	32.3M	33.0M	60.4M
Cash And Short Term Investments	101.0M	340.5M	266.3M	188.2M	192.8M	196.3M
Net Receivables	77.4M	124.4M	130.6M	254.7M	446.7M	469.1M
Common Stock Shares Outstanding	82.4M	84.9M	86.1M	93.7M	111.3M	70.4M
Liabilities And Stockholders Equity	1.5B	1.4B	1.4B	1.8B	2.7B	2.8B
Other Current Assets	200.5M	104.6M	127.1M	35.2M	44.1M	73.6M
Other Stockholder Equity	1.2B	1.2B	1.3B	1.5B	1.8B	1.9B
Total Liab	569.0M	750.6M	725.8M	957.9M	1.6B	1.7B
Total Current Assets	228.8M	546.1M	524.0M	478.1M	683.7M	354.3M
Intangible Assets	308.5M	268.1M	279.8M	442.8M	752.0M	789.6M
Other Liab	13.7M	455.2M	6.9M	55.4M	63.8M	71.7M
Current Deferred Revenue	19.8M	14.3M	11.9M	5.8M	6.0M	5.7M
Short Term Investments	1.8M	3.9M	75.7M	14.5M	13.8M	25.7M
Non Current Liabilities Total	376.2M	348.8M	280.3M	524.4M	938.4M	985.3M
Inventory	78.5M	(150.1M)	(445.1M)	(308.2M)	(415.9M)	1.05
Property Plant And Equipment Gross	157.3M	144.0M	250.7M	287.4M	248.7M	139.8M
Accumulated Other Comprehensive Income	(234K)	(278K)	(362K)	(1.2M)	(1.3M)	(1.3M)
Short Term Debt	6.3M	41.3M	14.1M	14.2M	19.5M	18.5M
Property Plant Equipment	85.2M	86.2M	81.4M	87.9M	101.1M	60.1M
Net Tangible Assets	41.8M	(3.2M)	(12.4M)	(306.1M)	(275.5M)	(261.8M)
Long Term Debt	293.7M	263.3M	215.7M	413.0M	597.0M	626.9M
Good Will	572.1M	354.7M	426.3M	722.8M	1.1B	707.6M
Common Stock Total Equity	846K	859K	908K	1.0M	1.2M	791.4K
Deferred Long Term Liab	1.9M	728K	1.4M	4.7M	4.3M	4.1M
Long Term Investments	139.4M	17.4M	5.5M	4.5M	4.9M	4.7M
Common Stock	846K	859K	908K	1.0M	1.2M	839.2K
Retained Earnings Total Equity	(252.0M)	(589.2M)	(626.8M)	(606.2M)	(545.5M)	(518.3M)

Currently Active Assets on Macroaxis

C	Citigroup
GM	General Motors
F	Ford Motor
GM	General Motors
V	Visa Class A

When determining whether Evolent Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Evolent Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Evolent Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Evolent Health Stock:

How To Invest In Evolent

Details

Is Evolent Stock a good investment?

Details

What is Evolent Health's Net Worth?

Details

Largest Health Care Technology Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evolent Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

For more detail on how to invest in Evolent Stock please use our How to Invest in Evolent Health guide.

You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Evolent Health. If investors know Evolent will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Evolent Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.92)

Revenue Per Share

21.554

Quarterly Revenue Growth

0.216

Return On Assets

0.0073

Return On Equity

(0.06)

The market value of Evolent Health is measured differently than its book value, which is the value of Evolent that is recorded on the company's balance sheet. Investors also form their own opinion of Evolent Health's value that differs from its market value or its book value, called intrinsic value, which is Evolent Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Evolent Health's market value can be influenced by many factors that don't directly affect Evolent Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Evolent Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Evolent Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Evolent Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Evolent End Period Cash Flow vs Other Non Cash Items Analysis

End Period Cash Flow vs Other Non Cash Items

End Period Cash Flow vs Other Non Cash Items Correlation Analysis

Correlation Coefficient

End Period Cash Flow

Other Non Cash Items

Evolent Health fundamental ratios Correlations

Evolent Health Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Evolent Health fundamental ratios Accounts

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Non Current Assets Total	+ 0.99	Total Assets
Total Current Liabilities	+ 0.99	Other Current Liab
Non Current Liabilities Total	+ 0.99	Total Liab
Intangible Assets	+ 0.98	Total Assets
Total Liab	+ 0.98	Other Current Liab
Total Liab	+ 0.98	Total Current Liabilities

Retained Earnings	- 0.9	Total Current Liabilities
Retained Earnings	- 0.89	Other Current Liab
Property Plant And Equipment Gross	- 0.87	Retained Earnings
Total Liab	- 0.85	Retained Earnings
Other Stockholder Equity	- 0.85	Retained Earnings
Non Current Liabilities Total	- 0.8	Retained Earnings